AstraZeneca announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supp…
Moderna, Inc. announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing to its existing Moderna Technology Center ("MTC") in Norwood, Massachusetts. Through this strategic onshoring, Moderna will now operate full end-to-end manufacturing for its mRNA medicines in t…
Novartis, a leading global innovative medicines company, announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in th…
Eli Lilly and Company announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing its distinctive model of scientific partnership to a city known for shaping the future of medicine. The new Gateway Labs site will occupy 44,000 square feet of 2300 Market, a life sciences facility in Center Ci…
Avantor, Inc. a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the opening of its newest Centralized Service Center (CSC) serving the Greater Boston area. The new facility in Watertown, Massachusetts, addresses the shor…
AIRS Medical, known for its award-winning AI-driven MRI solution, SwiftMR™, has rapidly emerged as a global force in diagnostic imaging innovation. Building upon this successful expansion, the company has continued to develop new partnerships throughout Europe, the Middle East, and Africa. SwiftMR: To Europe and Be…
Vieworks, a global leader in advanced X-ray imaging and industrial vision systems, has announced the successful completion of a large-scale expansion at its Hwaseong manufacturing campus, significantly increasing production capacity and operational flexibility to meet growing global demand. This strategic investment …
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, announced that its state-of-the-art current Good Manufacturing Practice ("c…
Cencora, a global pharmaceutical solutions company, announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an expanded presence in Alabama and…
October 2025 witnessed an exceptional surge in pharmaceutical and life sciences investments, underscoring global momentum in innovation, regional job creation, and supply chain localization. Leading organizations — including AstraZeneca, Eli Lilly, Moderna, Simtra BioPharma Solutions, ACG, Rentschler Biopharma, Ypsom…
Page 17 of 61